|
🐜
|
CD73 Immune Checkpoint Defines Regulatory NK-cells within the Tumor Microenvironment.
22 auth.
Shi-Yong Neo,
Ying Yang,
J. Record,
Ran Ma,
Xinsong Chen,
Ziqing Chen,
N. Tobin,
E. Blake,
C. Seitz,
R. Thomas,
...
A. Wagner,
J. Andersson,
J. de Boniface,
J. Bergh,
S. Murray,
E. Alici,
R. Childs,
M. Johansson,
L. Westerberg,
F. Haglund,
J. Hartman,
A. Lundqvist
|
7 |
2019 |
7
🐜
|
|
🐜
|
Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
11 auth.
C. Juhlin,
A. Villablanca,
K. Sandelin,
F. Haglund,
J. Nordenström,
L. Forsberg,
...
R. Bränström,
T. Obara,
A. Arnold,
C. Larsson,
A. Höög
|
6 |
2007 |
6
🐜
|
|
🐜
|
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
80 auth.
D. Tamborero,
R. Dienstmann,
M. Rachid,
J. Boekel,
A. López-Fernández,
Markus Jonsson,
A. Razzak,
I. Braña,
L. de Petris,
J. Yachnin,
Richard D. Baird,
Y. Loriot,
C. Massard,
P. Martin-Romano,
Frans L. Opdam,
...
R. Schlenk,
C. Vernieri,
M. Masucci,
Xenia Villalobos,
Elena Chavarria,
S. Anand,
Danny Baars,
S. Bajalica-Lagercrantz,
Richard D. Baird,
M. Bierkens,
L. Blomqvist,
Costanza Bono,
G. Doherty,
Arnauld Forest,
Valentina Fornerone,
Paola Gabaldi,
F. Haglund,
J. Hartman,
P. Horák,
T. Jutzi,
Mary A. Kasanicki,
S. Kreutzfeldt,
Lucian Le Cornet,
R. Lewensohn,
J. Lindberg,
Carlos Lopez,
Andreas Lundqvist,
José-Ezequiel Martín,
G. Meijer,
S. Muñoz,
M. N. Camus,
C. Nicotra,
P. Nuciforo,
Petra Oberrauch,
P. Östling,
Laura Pelz,
Alejandro Piris-Giménez,
E. Provenzano,
E. Rouleau,
John Rowell,
O. Saavedra,
Giovanni Scoazec,
K. Seamon,
M. Tischkowitz,
L. van der Kolk,
R. van der Noll,
M. Vieito,
D. Vis,
A. Vivancos,
C. von Gertten,
A. Wennborg,
L. Wessels,
V. Wirta,
J. Balmaña,
G. Apolone,
C. Caldas,
J. Bergh,
I. Ernberg,
S. Fröhling,
E. Garralda,
C. Karlsson,
J. Tabernero,
E. Voest,
J. Rodón,
J. Lehtiö
|
6 |
2022 |
6
🐜
|
|
🐜
|
Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas
7 auth.
C. Juhlin,
I. Nilsson,
K. Johansson,
F. Haglund,
A. Villablanca,
A. Höög,
...
C. Larsson
|
6 |
2010 |
6
🐜
|
|
🐜
|
Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
21 auth.
C. Juhlin,
Adam Stenman,
F. Haglund,
Victoria E. Clark,
Taylor C Brown,
J. Baranoski,
K. Bilguvar,
Gerald Goh,
J. Welander,
Fredrika Svahn,
...
Jill C. Rubinstein,
S. Caramuta,
Katsuhito Yasuno,
Murat Günel,
M. Bäckdahl,
O. Gimm,
P. Söderkvist,
M. Prasad,
R. Korah,
R. Lifton,
T. Carling
|
6 |
2015 |
6
🐜
|
|
🐜
|
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
7 auth.
C. Juhlin,
Nimrod B. Kiss,
A. Villablanca,
F. Haglund,
J. Nordenström,
A. Höög,
...
C. Larsson
|
6 |
2010 |
6
🐜
|
|
🐜
|
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells.
14 auth.
Ying Yang,
Shi-Yong Neo,
Ziqing Chen,
Weiyingqi Cui,
Yi Chen,
M. Guo,
Yongfang Wang,
Haiyan Xu,
A. Kurzay,
E. Alici,
...
L. Holmgren,
F. Haglund,
Kai Wang,
A. Lundqvist
|
5 |
2020 |
5
🐜
|
|
🐜
|
Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.
8 auth.
C. Juhlin,
F. Haglund,
A. Villablanca,
L. Forsberg,
K. Sandelin,
R. Bränström,
...
C. Larsson,
A. Höög
|
5 |
2009 |
5
🐜
|
|
🐜
|
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
13 auth.
Ran Ma,
Govindasamy-Muralidharan Karthik,
J. Lövrot,
F. Haglund,
Gustaf Rosin,
A. Katchy,
Xiaonan Zhang,
L. Viberg,
J. Frisell,
Cecilia Williams,
...
S. Linder,
I. Fredriksson,
J. Hartman
|
5 |
2017 |
5
🐜
|
